Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

RecruitingOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Colorectal CancerHead and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerCutaneous MelanomaEndometrial CancerUrothelial CarcinomaClear Cell Renal Cell Carcinoma
Interventions
PROCEDURE

Core Needle or Forceps Biopsy

Subjects must be clinically able, at investigator discretion, to undergo additional core needle or forceps biopsy passes during their biopsy. These additional biopsies may either be collected from the primary tumor or a metastatic site amenable to additional passes (e.g., liver or lymph nodes) per the clinician.

Trial Locations (11)

14203

NOT_YET_RECRUITING

Roswell Park Comprehensive Cancer Center, Buffalo

21742

RECRUITING

Meritus Center for Clinical Research, Hagerstown

NOT_YET_RECRUITING

Meritus Health, Hagerstown

27599

RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

32803

RECRUITING

AdventHealth Orlando, Orlando

33606

ACTIVE_NOT_RECRUITING

University of South Florida (Tampa General Hospital), Tampa

34994

RECRUITING

Cleveland Clinic Florida, Stuart

40202

RECRUITING

University of Louisville James Graham Brown Cancer Center, Louisville

53705

RECRUITING

University of Wisconsin, Madison

93901

RECRUITING

Salinas Valley Memorial Healthcare System, Salinas

07601

RECRUITING

John Theurer Cancer Center, Hackensack

Sponsors
All Listed Sponsors
collaborator

Hoosier Cancer Research Network

OTHER

lead

Elephas

INDUSTRY